about
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients
P50
description
researcher (ORCID 0000-0002-1353-7857)
@en
name
Satoshi Okazaki
@en
type
label
Satoshi Okazaki
@en
prefLabel
Satoshi Okazaki
@en
P31
P496
0000-0002-1353-7857